Agomab Spain S.l.u.
Clinical trials sponsored by Agomab Spain S.l.u., explained in plain language.
-
New drug could unblock Crohn's-Related bowel narrowing without surgery
Disease control Not yet recruitingThis trial tests an experimental drug called ontunisertib in people with Crohn's disease who have developed scarred, narrowed sections in their bowel that cause pain and blockages. The goal is to see if the drug can reopen these narrowed areas, potentially reducing symptoms and t…
Phase: PHASE2 • Sponsor: Agomab Spain S.L.U. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Radioactive tracer reveals how potential Crohn's drug moves through the body
Knowledge-focused Not yet recruitingThis trial in 8 healthy men aged 30–65 examines how the body absorbs, breaks down, and eliminates ontunisertib, an experimental oral drug for fibrostenotic Crohn's disease. Participants receive a single dose of the drug with a radioactive label, allowing researchers to track its …
Phase: PHASE1 • Sponsor: Agomab Spain S.L.U. • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC